Scentre Group (SCG) Investor presentation summary

Customer and community engagement

• Annual customer visits 554m, up 17m or 3.1% on pcp; 452m YTD, up 3.2% on pcp.

• Customer advocacy NPS 66, up 12 points on pcp; Westfield membership 5.4m, up 10.8% on pcp.

Business performance

• Occupancy 99.8%, in line with pcp and at record-high levels; business partner sales MAT $30.5bn, up $1bn on pcp.

• For the 9 months to September, total sales rose 3.7% and specialty sales rose 5.1% on a constant-currency basis.

• 9-month sales growth was strongest in health and beauty at 8.8%, jewellery at 8.6%, and technology and appliances at 5.9%; footwear declined 4.3%.

• 9-month regional sales growth ranged from 2.6% in QLD to 8.7% in NZ; NSW grew 2.8%, VIC 4.1%, and WA 6.0%.

• Completed 2,085 leasing deals; new specialty lease spreads were +3.7%.

Capital and investment management

• Issued US$750m of 10-year senior notes and $1.1bn at a margin of 141 bps over BBSW; re-entered the US bond market after six years.

• Settled a 50% joint venture of Westfield Mt Gravatt with ART for $882.5m.

• Available liquidity was $3.4bn, sufficient to cover all maturities until H2 2029.